699 related articles for article (PubMed ID: 25340601)
1. Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockade.
Giovannoni L; Muller YD; Lacotte S; Parnaud G; Borot S; Meier RP; Lavallard V; Bédat B; Toso C; Daubeuf B; Elson G; Shang L; Morel P; Kosco-Vilbois M; Bosco D; Berney T
Transplantation; 2015 Jan; 99(1):29-35. PubMed ID: 25340601
[TBL] [Abstract][Full Text] [Related]
2. Arsenic Trioxide Induces T Cell Apoptosis and Prolongs Islet Allograft Survival in Mice.
Gao C; Jiang J; Ma P; Cheng P; Lian Y; Zhao B; Li C; Peng Y; Wang F; Lin Y; Jin N; Li J; Wang L; Li Q; Leng Y; Xia J; Qi Z
Transplantation; 2015 Sep; 99(9):1796-806. PubMed ID: 25919768
[TBL] [Abstract][Full Text] [Related]
3. Roles of Toll-like receptors in allogeneic islet transplantation.
Ro H; Hong J; Kim BS; Lee EW; Kim MG; Han KH; Yeom HJ; Lee EM; Jeong JC; Oh KH; Ahn C; Yang J
Transplantation; 2012 Nov; 94(10):1005-12. PubMed ID: 23169223
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 4 suppression leads to islet allograft survival.
Goldberg A; Parolini M; Chin BY; Czismadia E; Otterbein LE; Bach FH; Wang H
FASEB J; 2007 Sep; 21(11):2840-8. PubMed ID: 17475921
[TBL] [Abstract][Full Text] [Related]
5. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
6. Early TLR4 Blockade Attenuates Sterile Inflammation-mediated Stress in Islets During Isolation and Promotes Successful Transplant Outcomes.
Chang CA; Murphy K; Kane RR; Lawrence MC; Naziruddin B
Transplantation; 2018 Sep; 102(9):1505-1513. PubMed ID: 29787520
[TBL] [Abstract][Full Text] [Related]
7. Treatment with Anti-FcεRIα (MAR-1) Antibody Prevents Acute Islet Allograft Rejection in a Murine Model.
Yazawa N; Imaizumi T; Makuuchi H; Tsuchiya I; Tanaka M; Inokuchi S; Habu S; Nakagohri T
Tokai J Exp Clin Med; 2015 Dec; 40(4):141-8. PubMed ID: 26662664
[TBL] [Abstract][Full Text] [Related]
8. Immunoprotection and Functional Improvement of Allogeneic Islets in Diabetic Mice, Using a Stable Indoleamine 2,3-Dioxygenase Producing Scaffold.
Hosseini-Tabatabaei A; Jalili RB; Khosravi-Maharlooei M; Hartwell R; Kilani RT; Zhang Y; Ghahary A
Transplantation; 2015 Jul; 99(7):1341-8. PubMed ID: 25769070
[TBL] [Abstract][Full Text] [Related]
9. Anti-CCL25 antibody prolongs skin allograft survival by blocking CCR9 expression and impairing splenic T-cell function.
Li J; Xiong T; Xiao R; Xiong A; Chen J; Altaf E; Zheng Y; Zhu G; He Y; Tan J
Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):237-44. PubMed ID: 23456208
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
[TBL] [Abstract][Full Text] [Related]
11. Islet allograft rejection is independent of toll-like receptor signaling in mice.
Hutton MJ; Westwell-Roper C; Soukhatcheva G; Plesner A; Dutz JP; Verchere CB
Transplantation; 2009 Nov; 88(9):1075-80. PubMed ID: 19898202
[TBL] [Abstract][Full Text] [Related]
12. Murine islet allograft tolerance upon blockade of the B-lymphocyte stimulator, BLyS/BAFF.
Parsons RF; Yu M; Vivek K; Zekavat G; Rostami SY; Ziaie AS; Luo Y; Koeberlein B; Redfield RR; Ward CD; Migone TS; Cancro MP; Naji A; Noorchashm H
Transplantation; 2012 Apr; 93(7):676-85. PubMed ID: 22262127
[TBL] [Abstract][Full Text] [Related]
13. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
[TBL] [Abstract][Full Text] [Related]
14. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
[TBL] [Abstract][Full Text] [Related]
16. Anergic T cells generated in vitro suppress rejection response to islet allografts.
Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
Transplantation; 2000 May; 69(10):2144-8. PubMed ID: 10852614
[TBL] [Abstract][Full Text] [Related]
17. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts.
Takeda Y; Gotoh M; Dono K; Nishihara M; Grochowiecki T; Kimura F; Yoshida T; Ohta Y; Ota H; Ohzato H; Umeshita K; Takeda T; Matsuura N; Sakon M; Kayagaki N; Yagita H; Okumura K; Miyasaka M; Monden M
Diabetologia; 1998 Mar; 41(3):315-21. PubMed ID: 9541172
[TBL] [Abstract][Full Text] [Related]
18. Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance.
Fan K; Wang H; Wei H; Zhou Q; Kou G; Hou S; Qian W; Dai J; Li B; Zhang Y; Zhu T; Guo Y
Transplantation; 2007 Sep; 84(6):746-54. PubMed ID: 17893608
[TBL] [Abstract][Full Text] [Related]
19. Donor-Specific Regulatory T Cell-Mediated Immune Tolerance in an Intrahepatic Murine Allogeneic Islet Transplantation Model with Short-Term Anti-CD154 mAb Single Treatment.
Lee SJ; Kim HJ; Byun NR; Park CG
Cell Transplant; 2020; 29():963689720913876. PubMed ID: 32216448
[TBL] [Abstract][Full Text] [Related]
20. Operational immune tolerance towards transplanted allogeneic pancreatic islets in mice and a non-human primate.
Abdulreda MH; Berman DM; Shishido A; Martin C; Hossameldin M; Tschiggfrie A; Hernandez LF; Hernandez A; Ricordi C; Parel JM; Jankowska-Gan E; Burlingham WJ; Arrieta-Quintero EA; Perez VL; Kenyon NS; Berggren PO
Diabetologia; 2019 May; 62(5):811-821. PubMed ID: 30701283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
